Information about Octimet Oncology
My details
*
*
*

Octimet Oncology (SA)

Company information

Status
Active

Enterprise number

BE0651.853.757

VAT liability
Yes
Established
12-04-2016
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Octimet Oncology

2024 2023 2022 2021
Profit/Loss 179,816 236 % -131,817 10 % -146,453 4 % -152,305
Equity 339,354 108 % -4,168,239 -3 % -4,036,423 -4 % -3,889,970
Gross margin -56,278 -2127 % 2,777 114 % -19,537 72 % -68,960

Publications from Octimet Oncology

Date Publication
14-06-2024 Resignations - Appointments (NL)
07-03-2024 Modification(s) Articles of Association (NL)
19-02-2024 Resignations - Appointments (NL)
15-02-2024 Modification(s) Articles of Association (NL)
11-10-2023 Articles of Association (Translation, Coordination, Other Modifications, …) (NL)

Frequently asked questions

What is the VAT number of Octimet Oncology?
The VAT number of Octimet Oncology is BE 0651.853.757.
Wat is the PEPPOL ID of Octimet Oncology?
There is no information available about the PEPPOL ID of Octimet Oncology or the company is not yet registered on the PEPPOL network.
When was Octimet Oncology founded?
Octimet Oncology was founded on 12-04-2016.
What is the address of Octimet Oncology?
The current registered office of Octimet Oncology is located at Oudepostelseweg 1, 2440 Geel.
When was the last time Octimet Oncology filed their annual financial statements?
The most recent financial statements of Octimet Oncology were filed on 23-06-2025.
How many employees does Octimet Oncology have?
There are currently no employees working at Octimet Oncology or no workforce information is available.
What is the annual turnover of Octimet Oncology?
At the time of its most recent financial statements, Octimet Oncology did not publish any turnover figures. Octimet Oncology reported a gross margin of -€56,277.64.